全文获取类型
收费全文 | 1276593篇 |
免费 | 92937篇 |
国内免费 | 1991篇 |
专业分类
耳鼻咽喉 | 18198篇 |
儿科学 | 42262篇 |
妇产科学 | 37815篇 |
基础医学 | 187002篇 |
口腔科学 | 35381篇 |
临床医学 | 108116篇 |
内科学 | 251537篇 |
皮肤病学 | 26527篇 |
神经病学 | 99184篇 |
特种医学 | 49992篇 |
外国民族医学 | 366篇 |
外科学 | 197610篇 |
综合类 | 26519篇 |
现状与发展 | 1篇 |
一般理论 | 300篇 |
预防医学 | 92589篇 |
眼科学 | 29063篇 |
药学 | 97762篇 |
1篇 | |
中国医学 | 2497篇 |
肿瘤学 | 68799篇 |
出版年
2018年 | 11810篇 |
2015年 | 11612篇 |
2014年 | 15997篇 |
2013年 | 24349篇 |
2012年 | 33542篇 |
2011年 | 35940篇 |
2010年 | 21209篇 |
2009年 | 20013篇 |
2008年 | 34973篇 |
2007年 | 37944篇 |
2006年 | 38499篇 |
2005年 | 37794篇 |
2004年 | 36377篇 |
2003年 | 35369篇 |
2002年 | 34917篇 |
2001年 | 58093篇 |
2000年 | 59584篇 |
1999年 | 50687篇 |
1998年 | 14233篇 |
1997年 | 12809篇 |
1996年 | 13071篇 |
1995年 | 12345篇 |
1994年 | 11757篇 |
1993年 | 10860篇 |
1992年 | 40984篇 |
1991年 | 40358篇 |
1990年 | 39885篇 |
1989年 | 38708篇 |
1988年 | 36111篇 |
1987年 | 35349篇 |
1986年 | 33725篇 |
1985年 | 32137篇 |
1984年 | 23922篇 |
1983年 | 20819篇 |
1982年 | 12377篇 |
1981年 | 10927篇 |
1980年 | 10205篇 |
1979年 | 22640篇 |
1978年 | 15879篇 |
1977年 | 13729篇 |
1976年 | 12970篇 |
1975年 | 14201篇 |
1974年 | 16683篇 |
1973年 | 16076篇 |
1972年 | 15318篇 |
1971年 | 14229篇 |
1970年 | 13214篇 |
1969年 | 12731篇 |
1968年 | 11979篇 |
1967年 | 10478篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Aaron Yarlas Martha Bayliss Joseph C. Cappelleri Stephen Maher Andrew G. Bushmakin Lea Ann Chen Alireza Manuchehri Paul Healey 《Quality of life research》2018,27(2):273-290
Purpose
To conduct a systematic literature review of the reliability, construct validity, and responsiveness of the SF-36® Health Survey (SF-36) in patients with ulcerative colitis (UC).Methods
We performed a systematic search of electronic medical databases to identify published peer-reviewed studies which reported scores from the eight scales and/or two summary measures of the SF-36 collected from adult patients with UC. Study findings relevant to reliability, construct validity, and responsiveness were reviewed.Results
Data were extracted and summarized from 43 articles meeting inclusion criteria. Convergent validity was supported by findings that 83% (197/236) of correlations between SF-36 scales and measures of disease symptoms, disease activity, and functioning exceeded the prespecified threshold (r ≥ |0.40|). Known-groups validity was supported by findings of clinically meaningful differences in SF-36 scores between subgroups of patients when classified by disease activity (i.e., active versus inactive), symptom status, and comorbidity status. Responsiveness was supported by findings of clinically meaningful changes in SF-36 scores following treatment in non-comparative trials, and by meaningfully larger improvements in SF-36 scores in treatment arms relative to controls in randomized controlled trials. The sole study of SF-36 reliability found evidence supporting internal consistency (Cronbach’s α ≥ 0.70) for all SF-36 scales and test–retest reliability (intraclass correlation coefficient ≥0.70) for six of eight scales.Conclusions
Evidence from this systematic literature review indicates that the SF-36 is reliable, valid, and responsive when used with UC patients, supporting the inclusion of the SF-36 as an endpoint in clinical trials for this patient population.92.
93.
94.
95.
96.
97.
98.
N. Guiso J.-L. Gallais G. Gavazzi D. Pinquier J. Gaillat 《Médecine et maladies infectieuses》2018,48(1):30-36
Objective
To assess the incidence of pertussis (whooping cough) in subjects aged 50 years and older in France.Methods
Participating family physicians (FPs) using the patient record management software AxiSanté® included patients aged 50 years and older, who had signed an informed consent form, presenting with persistent cough for 7 to 21 days. Bordetella genetic material was detected by polymerase chain reaction (PCR) on nasopharyngeal samples collected at the FP's discretion.Results
A total of 42 FPs included 129 patients from June 2013 to August 2014 (large cities: 38; medium-sized cities: 57; rural areas: 34); 106 samples were analyzed. Overall, 30 pertussis cases were diagnosed: 10 cases confirmed by PCR, 18 purely clinical cases, and two direct epidemiological cases. The crude incidence rate per 100,000 patients aged ≥ 50 years was 103.6 (95% CI: 69.9–47.9): 77.1 in large cities, 103.1 in medium-sized cities, and 143.9 in rural areas. The extrapolated incidence rate per 100,000 persons aged ≥ 50 years was 187.1 (95% CI: 126.2–67.1): 131.1 in large cities, 256.1 in medium-sized cities, and 242.2 in rural areas.Conclusion
The population aged 50 years and older can serve as a reservoir. Its role in Bordetella pertussis circulation should be taken into account for pertussis booster vaccination programs. 相似文献99.
100.
Kristina N. Ekdahl Padideh Davoodpour Barbro Ekstrand-Hammarström Karin Fromell Osama A. Hamad Jaan Hong Anders Bucht Camilla Mohlin Gulaim A. Seisenbaeva Vadim G. Kessler Bo Nilsson 《Nanomedicine : nanotechnology, biology, and medicine》2018,14(3):735-744
Iron-oxide nanoparticles (NPs) generated by environmental events are likely to represent health problems. α-Fe2O3 NPs were synthesized, characterized and tested in a model for toxicity utilizing human whole blood without added anticoagulant. MALDI-TOF of the corona was performed and activation markers for plasma cascade systems (complement, contact and coagulation systems), platelet consumption and release of growth factors, MPO, and chemokine/cytokines from blood cells were analyzed. The coronas formed on the pristine α-Fe2O3 NPs contained contact system proteins and they induced massive activation of the contact (kinin/kallikrein) system, as well as thrombin generation, platelet activation, and release of two pro-angiogeneic growth factors: platelet-derived growth factor and vascular endothelial growth factor, whereas complement activation was unaffected. The α-Fe2O3 NPs exhibited a noticeable toxicity, with kinin/kallikrein activation, which may be associated with hypotension and long-term angiogenesis in vivo, with implications for cancer, arteriosclerosis and pulmonary disease. 相似文献